Bard clarification
This article was originally published in The Gray Sheet
Executive Summary
Firm's anti-infection endotracheal tube is coated with a new formulation of silver hydrogel anti-microbial technology internally developed by Bard and specifically formulated to address ventilator-associated pneumonia. The device does not use BactiGuard technology, as previously reported (1"The Gray Sheet" April 21, 2003, p. 21)...